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Abstract—The nonsteroidal anti-inflammatory drug diclofenac is extremely toxic to Old World Gyps vultures (median lethal dose
0.1–0.2 mg/kg), evoking visceral gout, renal necrosis, and mortality within a few days of exposure. Unintentional secondary
poisoning of vultures that fed upon carcasses of diclofenac-treated livestock decimated populations in the Indian subcontinent.
Because of the widespread use of diclofenac and other cyclooxygenase-2 inhibiting drugs, a toxicological study was undertaken
in turkey vultures (Cathartes aura) as an initial step in examining sensitivity of New World scavenging birds. Two trials were
conducted entailing oral gavage of diclofenac at doses ranging from 0.08 to 25 mg/kg body weight. Birds were observed for 7 d,
blood samples were collected for plasma chemistry (predose and 12, 24, and 48 h and 7 d postdose), and select individuals were
necropsied. Diclofenac failed to evoke overt signs of toxicity, visceral gout, renal necrosis, or elevate plasma uric acid at concen-
trations greater than 100 times the estimated median lethal dose reported for Gyps vultures. For turkey vultures receiving 8 or 25
mg/kg, the plasma half-life of diclofenac was estimated to be 6 h, and it was apparently cleared after several days as no residues
were detectable in liver or kidney at necropsy. Differential sensitivity among avian species is a hallmark of cyclooxygenase-2
inhibitors, and despite the tolerance of turkey vultures to diclofenac, additional studies in related scavenging species seem warranted.
Keywords—Diclofenac Scavenging birds Species sensitivity Vultures
INTRODUCTION
Diclofenac is a nonsteroidal anti-inflammatory drug
(NSAID) used by veterinarians for the treatment of inflam-
mation, fever, and pain in domestic livestock. This drug ap-
pears to have been the principal cause of a population crash
of Old World vultures (genus Gyps) in India, Pakistan, and
Nepal [1–5]. Vultures unintentionally ingested diclofenac
when scavenging carcasses of livestock that had been treated
with this drug shortly before death. This is perhaps the only
well-documented instance of a veterinary or human drug re-
sulting in an adverse population-level response in nontarget
free-ranging wildlife.
Based upon observational and experimental data, the me-
dian lethal dose (LD50) of diclofenac in Oriental white-backed
vulture (Gyps bengalensis) was estimated to be 0.098 mg/kg
body weight (95% CI, 0.027–0.351 mg/kg), and 0.225 mg/kg
(95% CI, 0.117–0.432 mg/kg) when an outlier was excluded
[1,6]. Oral dosing of Eurasian (G. fulvus) and African (G.
africanus) vultures with diclofenac at 0.8 mg/kg body weight
has been shown to evoke a substantial increase in plasma uric
acid, which is indicative of altered renal function, and dosed
birds succumb within 48 h [6]. Based upon lethality data,
diclofenac can be categorized as extremely toxic to Gyps vul-
tures. Pathological signs in affected vultures include visceral
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gout (grossly visible urate deposits on internal organs) that is
the result of kidney failure [1]. Acute necrosis of the proximal
convoluted tubules in affected individuals is severe [7]. Di-
clofenac is known to be a potent inhibitor of cyclooxygenase-
2 and prostaglandin synthetase. From a mechanistic perspec-
tive, it has been hypothesized that impaired production of pros-
taglandins E2 and I2 may alter smooth muscle control of the
renal portal valve and shunt blood from the renal cortex; this
would result in ischemia and necrosis of the proximal con-
voluted tubules [7]. Similar pathology has also been reported
in domestic fowl (Gallus gallus), although they seem to be
considerably more tolerant to diclofenac (median lethal dose
estimate of 9.8 mg/kg when administered intramuscularly) [8].
Although veterinary use of diclofenac in India is being
phased out and an alternative that is not toxic to Gyps vultures
has been identified (meloxicam [9]), widespread sale and vet-
erinary and human use of diclofenac continues on a global
scale [10,11] (http://www.birdlife.org/news/news/2007/11/
africadiclofenac.html; accessed 19 December 2007). At pres-
ent there are no data on diclofenac-induced mortality in free-
ranging birds of prey in North and South America. While New
and Old World vultures are not closely related, data on diclo-
fenac toxicity to New World vultures is warranted for several
reasons. Notably, simple extrapolation of diclofenac toxicity
data for Gyps vultures (order Falconiformes family Accipitri-
dae) may not adequately assess risk in New World vultures
(order Ciconiiformes family Cathartidae) due to taxonomic and
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genetic distinctions; diclofenac is easy to manufacture, inex-
pensive, and readily accessible in many undeveloped countries
for treatment of livestock; seven species of vultures are found
in North and South America and numerous reports in devel-
oped countries document poisoning of raptors that fed on an-
imal carcasses treated with veterinary drugs (barbiturates) or
exposed to pesticides [12–16]; carcass burial and disposal
practices are less sophisticated on ranches with large open
range, in remote regions, and in undeveloped countries, in-
creasing the likelihood of exposure; modeling studies suggest
that even the rare presence of contaminated carcasses can have
significant population effects on vultures [5]; comparative tox-
icological aspects of nonsteroidal anti-inflammatory drugs are
poorly known in birds [11,17–19]; and there is growing con-
cern for the ecotoxicological effects of veterinary pharmaceu-
ticals released from animal feed lot operations into streams
and estuaries [20,21]. Finally, other currently used NSAIDs,
including carprofen and flunixin, have been associated with
mortality, gout, and/or renal failure in some scavenging birds
outside of the Gyps genus [11], and thus their toxicity would
also merit urgent investigation should diclofenac prove ex-
tremely toxic to New World vultures. For these reasons, and
given worldwide conservation concerns for scavenging birds
(e.g., California condor [Gymnogyps californianus] and bald
eagle [Haliaeetus leucocephalus]) that may be unintentionally
exposed to NSAIDs, a study was undertaken examining di-
clofenac toxicity to turkey vultures (Cathartes aura) as an
initial step in determining sensitivity among species potentially
at risk.
MATERIALS AND METHODS
Animals
The present study was conducted at The Center for Birds
of Prey in Charleston, South Carolina, USA, during April to
June of 2007. During dosing trials ambient temperature ranged
from approximately 10.6 to 32.2C. Captive adult turkey vul-
tures (n  7 males and 4 females) that were not candidates
for release (improperly healed shoulder and wing fractures)
were obtained from various rehabilitation facilities. Birds were
housed individually in outdoor pens (10–12 feet wide  10–
12 feet long 10 feet high; pressure-treated lumber with vinyl-
coated wire, and a roof for shade) and fed 150 to 200 g skinned
rats (Rodentpro, Evans, IN, USA) or whole chicks (Mike Du-
puy’s Hawk Food, Silver Spring, MD, USA) supplemented
with Vionate (Gimborn US, Atlanta, GA, USA) and calcium
on a daily basis between 10:00 AM and noon. A bowl con-
taining fresh water was present in each pen. Birds were ac-
climated to housing and husbandry activities for several weeks,
and were handled and weighed at least weekly.
Physical exams, hematology, plasma clinical chemistries,
and electrophoresis (Advanced Well Bird Exam; Comparative
Pathology Laboratory, University of Miami, Miller School of
Medicine, Miami, FL, USA) indicated that birds were in gen-
erally good health. Plasma samples were screened for West
Nile Virus exposure using enzyme-linked immunosorbent as-
say and by plaque reduction neutralization assay on vero cells
at a starting dilution of 1:20 and using a 90% neutralization
rule [22]. Notably, two vultures had been exposed to West Nile
Virus in the past. Results for another bird were equivocal for
West Nile Virus and St. Louis encephalitis, and positive for
flavivirus exposure; this individual had elevated serum gamma
globulin and plasma aspartate and alanine aminotransferase
activities, but was ultimately included in trial 2 as plasma
enzyme activities had declined substantially.
Diclofenac-dosing solutions
Because of difficulties in the importation of the veterinary
formulation of diclofenac used in the Indian subcontinent,
technical grade sodium diclofenac (2-[(2,6-dichlorophen-
yl)amino]benzeneacetic acid sodium salt;99% purity; Chem-
ical Abstract Service no. 15307-79-6) was purchased from
Sigma-Aldrich (St. Louis, MO, USA). A 2.5 mg/ml stock so-
lution was prepared by dissolving sodium diclofenac in dis-
tilled water on a stirring hot plate at 30C. Dosing solutions
were prepared by addition of various quantities of this stock
into distilled water in volumetric flasks. Nominal concentra-
tions ranged from 0.16 to 25 mg sodium diclofenac/ml, and
were analytically verified (recovery averaged 104.9%; meth-
ods described below). Solutions were administered in a volume
of 0.5 ml/kg body weight, and nominal doses ranged from 0.08
to 12.5 mg/kg body weight. Due to limits of solubility, the
greatest dose, 25 mg/kg body weight, was administered in
twice the volume (1 ml/kg body wt).
Dosing and sampling procedures
Regurgitation of stomach contents is an acknowledged
problem when conducting studies with vultures. In advance of
dosing trials, each bird was handled and sham-dosed on several
occasions with water (0.5 ml/kg body wt) orally administered
(behind the glottis) using a 2.5 ml luer lock syringe (Hamilton
Company, Reno, NV, USA) with an 18 gauge 3.8 cm long ball
point intubation needle (Popper and Sons, New Hyde Park,
NY, USA).
For study trials, each bird was weighed and a 1 to 2 ml
brachial venipuncture sample for blood chemistry and diclo-
fenac residues was collected between 8:00 and 10:00 AM (time
0). Birds were then fed, and food scraps were removed from
pens in the late afternoon 16 h before dosing. On the day of
dosing, each vulture was captured, briefly restrained (2 min),
orally dosed, and released, at staggered 15-min intervals be-
tween 8:00 and 10:20 AM, and then fed 4 h after dosing. Birds
were observed for signs of intoxication at hourly intervals
during daylight and at 4-h intervals during the night for 2 d,
and then at 4-h intervals during day light for five additional
days. Body weight was determined and a 1 to 2 ml blood
sample was collected at 12, 24, and 48 h, and 7 d postdosing.
Birds were then lightly anesthetized with isoflurane and eu-
thanized with pentobarbital. These procedures had been eval-
uated and approved by the Institutional Animal Care and Use
Committees of The Center for Birds of Prey and the Patuxent
Wildlife Research Center (Beltsville, MD, USA).
Euthanized birds were tagged for identification, placed in
doubled plastic bags, chilled in a freezer and express shipped
in a cooler lined with freezer packs to the National Wildlife
Health Center (Madison, WI, USA). A detailed necropsy (ex-
ternal and internal examination, weights of liver and kidney,
fixation of major organs in 10% neutral buffered formalin) was
conducted on each bird within 48 h of euthanasia. Liver from
each bird was tested for bacteria using standard aerobic culture
techniques on blood agar. Kidney was cultured for virus using
vero cell cultures to isolate viruses [23]. Subsamples of liver
and kidney were placed in chemically clean jars (ICHEM Re-
search, New Castle, DE, USA) and frozen at 	10C for sub-
sequent diclofenac residue analysis. Portions of formalin-fixed
liver, kidney, brain, trachea, lung, heart, digestive tract, en-
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docrine organs, and spleen were processed for histopathology
using standard methods, sectioned at 5 
m, stained with he-
matoxylin and eosin (Histology Laboratory of the Department
of Pathobiology, College of Veterinary Medicine, University
of Wisconsin, Madison, WI, USA), and examined by light
microscopy.
Analytical methods
Dosing solutions, blood plasma, and liver and kidney sam-
ples were shipped on dry ice to the University of Aberdeen
(UK) for diclofenac analysis. Dosing solutions were gently
heated to redissolve diclofenac. Dosing solutions and blood
plasma samples were vortex mixed with acetonitrile, while
liver and kidney samples were homogenized in acetonitrile.
All samples were filtered and quantified by liquid chromatog-
raphy–electrospray ionization mass spectrometry using an
Agilent 1100 series instrument (1946D; Agilent Technologies,
Stockport, UK). Details of this procedure have recently been
published [24]. For tissue samples the limit of quantification
was 10 
g/kg and the limit of detection was 4 
g/kg.
Blood samples were express shipped and analyzed at the
Avian and Wildlife Laboratory of the Division of Comparative
Pathology (University of Miami, FL, USA). Initial health
checks included complete blood counts [25], serum electro-
phoresis [26], hematocrit and a chemistry panel (enzymes:
alanine aminotransferase, amylase, aspartate aminotransferase,
creatine phosphokinase, lactic dehydrogenase, lipase, and
gamma glutamyl transferase; electrolytes and minerals: sodi-
um, potassium, carbon dioxide, calcium, and phosphorus; other
analytes: glucose, blood urea nitrogen, uric acid, creatinine,
cholesterol, triglycerides, and total protein) using dry-slide
reagents and a Vitros 250 Chemistry System (Ortho Diagnos-
tics, Rochester, NY, USA) (Kossoff S, Bladow R, Luya M,
Cray C. 2001. Association of Avian Veterinarians Newsletter
and Clinical Forum, Sept–Nov, 2001, pp 6–7). Only hemat-
ocrit and the 19 analyte blood chemistry panel were conducted
on samples collected during the dosing trials.
Statistical analysis
Relations among administered dose, body and organ weight
change, and plasma diclofenac concentrations were examined
using Pearson product-moment correlation. Approximation of
diclofenac plasma half-life and its elimination constant were
obtained using a simple first-order kinetic model (http://
www-users.med.cornell.edu/spon/picu/calc/halfcalc.htm).
Dose–responses, and temporal change in the dose–response
relations, were investigated for 20 blood chemistry constituents
using a repeated measures model with controls for baseline
differences between the two trial periods. The data for each
blood chemistry constituent consist of measurements, yi i 
1, 2, . . . , 80. Our model was that
y  Bird  (   Treatment )  k Trial  i B(i) j(i) j(i) i i i
where B(i) identifies the bird associated with measurement i,
B(i)  1, 2, . . . , 11. Index j(i) describes the measurement
time, with j(i)  0, 1, 2, 3, 4 for measurement times 	24, 12,
24, 48, and 168 h from dosing. Covariate ki  0 for the original
trial, and ki  1 for the second trial. Thus the model includes
bird specific normal random effects (Bird), a time-specific lin-
ear regression on treatment level (  Treatment), a change
in level associated with the two trial occasions (Trial), and a
mean zero normal error term ().
This model is easily fit using a Bayesian approach with the
program WinBUGS [27]. Standard vague priors for regression
coefficients and variance components were employed.
RESULTS AND DISCUSSION
To test the hypothesis that turkey vultures and Old World
vultures (Oriental white-backed, Eurasian, and African) are
equally sensitive to diclofenac, data on its lethality to the Ori-
ental white-backed vultures (LD50 of 0.098–0.225 mg/kg)
[1,6] were used to select doses at and well-above levels pre-
sumed to evoke toxicity. Compared to sham-dosed controls (n
 1 male, 1 female), no overt signs of toxicity were apparent
when turkey vultures were administered diclofenac at 0.08 mg/
kg (n  1 female), 0.25 mg/kg (n  1 female, 2 males), 0.8
mg/kg (n  1 female, 2 males), and 2.5 mg/kg body weight
(n  1 male), and all birds survived the 7-d trial. Rather than
sacrifice all of the vultures used in this trial, the decision was
made to euthanize only half (i.e., one sham-dosed, one dosed
at 0.25 mg/kg, two dosed at 0.8 mg/kg, and the single bird
administered 2.5 mg/kg) and re-expose remaining birds to
greater concentrations of diclofenac.
Three weeks following the initial study, a second trial was
conducted with previously dosed birds plus an additional vul-
ture. Treatments included sham-dosed (n 1 male not included
in trial 1), and vultures dosed with diclofenac at 2.5 mg/kg (n
 1 female previously sham-dosed in trial 1), 8 mg/kg (n 
1 female and 1 male previously dosed with 0.08 and 0.25 mg/
kg, respectively), and 25 mg/kg body weight (n  2 males
previously dosed with 0.25 or 0.8 mg/kg body wt). Notably,
diclofenac concentrations given to redosed birds were 31.25
to 100 times the quantity administered in trial 1. No overt
signs of toxicity were observed during trial 2, which included
diclofenac doses exceeding its LD50 in Gyps vultures by more
than two orders of magnitude.
Over the 7-d time course of trials 1 and 2, slight fluctuations
in body weight were noted (ranging from 0.72 to 	6.38%)
compared to predosing weight (time 0), although changes were
not associated ( p  0.05) with dosage level of diclofenac. At
necropsy, neither liver to body weight nor kidney to body
weight ratios were related ( p  0.50) to dose of administered
diclofenac.
Necropsies indicated that turkey vultures were in good flesh
and had moderate amounts of subcutaneous fat. With rare ex-
ception (e.g., occasional enlarged spleen, one instance of
healed hepatic fracture), their internal organs were grossly
unremarkable. Histopathological examination revealed multi-
focal areas of cytoplasmic vacuolation of renal subcortical
cells, and mild periportal inflammation and hepatocellular vac-
uolation, in all vultures regardless of diclofenac dose. Scant
dark deposits associated with granulomatous inflammation
were observed in a few collecting tubules and fewer distal
convoluted tubules in one of two tissue sections from one
vulture that received 25 mg diclofenac/kg body weight. This
was suggestive of urate deposits reminiscent of a past dehy-
dration event rather than diclofenac intoxication. Clearly, no
lesions were seen in any of the turkey vultures that would have
contributed to death other than those associated with isoflur-
ane–pentobarbital euthanasia. This is in direct contrast to ob-
servations of visceral gout [1,3,6] in several species of Gyps
vultures naturally exposed to or experimentally treated with
diclofenac, and the urate aggregates and acute necrosis of the
proximal convoluted tubules [7] observed in naturally exposed
Oriental white-backed vultures.
No diclofenac residues were detected in turkey vulture liver
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Table 1. Plasma diclofenac concentration in turkey vultures in trials 1 and 2a
Dose (mg/kg) Trial n
Plasma diclofenac (ng/ml)
	24 h 12 h 24 h 48 h 7 d
0 1, 2 3 — — — — —
0.08 1 1 — 7 — —
0.25 1 3 — 12 (6, 13, 17) — — —
0.8 1 3 — 66 (40, 62, 96) 6.3 (4, 5, 10) — —
2.5 1, 2 2 — 326 (76, 577) 118 (14, 221) — (–, 82) —
8 2 2 — 937 (420, 1454) 227 (94, 360) 17 (11, 23) —
25 2 2 — 13,845 (6350, 21340) 513 (245, 781) 330 (16, 645) —
a Values are mean (individual values); —  not detected.
Fig. 1. Plasma uric acid concentration (solid lines indicate range of
observed values) in Gyps vultures (n  2 Gyps fulvus and n  3
Gyps africanus) orally dosed with 0.80 mg diclofenac/kg body weight;
†  approximate time of death (adapted from Swan et al. [6]). Plasma
uric acid concentration (dashed lines indicate range of observed val-
ues) in Cathartes aura orally dosed with 0.80, 2.5, 8, and 25 mg
diclofenac/kg body weight (n  2 birds from trial 1 plus four redosed
birds used in trial 2); no mortality occurred.
or kidney 7 d after administration of doses ranging up to 25
mg/kg body weight. This is in contrast to Gyps vultures that
died with detectable diclofenac in liver and kidney within 2
d of its administration [6]. Diclofenac was detected in blood
plasma of turkey vultures up to 48 h after administration in
trials 1 and 2, and was apparently cleared by day 7 (Table 1).
When data for turkey vultures in trial 1 and 2 were combined
in a regression analysis, plasma diclofenac concentrations were
dose dependent at 12 h [r  0.92; p  0.001, n  16;
log10(plasma diclofenac)  	1.062  0.088(log10dose)] and
at 24 h [r  0.74; p  0.025, n  16; log10(plasma diclofenac)
 	1.796  0.065(log10dose)]. Using plasma diclofenac values
at 12 and 48 h after administration of 8 and 25 mg/kg, and
assuming steady state conditions, a rough estimate of the plas-
ma half-life (mean  standard deviation) of diclofenac in tur-
key vultures was 6.04  1.33 h with an elimination constant
of 0.12  0.03. This half-life is markedly greater than the
1-h half-life estimated from a detailed pharmacologic study in
domestic fowl, but less than the 14- to 18-h half-life estimated
for Gyps vultures [8].
Based upon previous observations of elevated plasma uric
acid concentration and alanine aminotransferase activity in
Gyps vultures administered 0.8 mg diclofenac/kg body weight
[6], we focused greatest attention on these analytes. Using data
from both trials 1 and 2, plasma concentrations of uric acid
were not affected by diclofenac administration ( p  0.05).
Unlike Gyps vultures [6], uric acid concentrations in turkey
vultures were not linearly related to diclofenac dose at 12 h
( p  0.50) or 24 h ( p  0.10) postadministration. For com-
parative purposes, concentrations of plasma uric acid in both
turkey vultures and Gyps vultures are presented in Figure 1.
A slight elevation ( p  0.05) in uric acid levels were noted
in all (sham- and diclofenac-dosed) turkey vultures after 12 h
(evening, 8:00 to 10:00 PM), perhaps reflecting a postprandial
or circadian fluctuation, and concentrations were modestly de-
pressed in all birds after 24 and 48 h. Plasma alanine ami-
notransferase activity was neither affected by dose of diclo-
fenac nor sampling time ( p  0.05).
Of the other analytes, the most pronounced effects of di-
clofenac included depressed plasma potassium levels at 12 and
24 h postadministration ( p  0.05; n  4 birds that received
8 and 25 mg/kg combined; mean  standard deviation of 3.78
 0.15 at 12 h and 3.57  0.10 mmol/L at 24 h vs 3.98 
0.10 at time 0, n  16), which is in contrast to hyperkalemia
noted in diclofenac-intoxicated Gyps species and chickens [8].
In addition, plasma lactic dehydrogenase activity was seeming
elevated by higher doses of diclofenac at 24 h ( p  0.05; n
 9 birds that received 0.8, 2.5, 8, and 25 mg/kg; 957  278
IU/L at 24 h versus 786  243 at time 0, n  16). Dose-
related effects were detected for plasma sodium at 12 and 24
h, blood urea nitrogen at 24 and 48 h, carbon dioxide at 48
h, creatinine at 48 h, amylase on day 7, and lipase at 48 h and
on day 7, but values were within the range observed at other
sampling times, overlapped the range of values reported for
other birds of prey (Andean condor, Vultur gryphus [28]; Eur-
asian vulture and Egyptian vulture, Neophron pernopterus
[29]) and fluctuations were seemingly modest from a physi-
ological and toxicological standpoint. Hematocrit, plasma as-
partate aminotransferase, and creatine phosphokinase activities
and calcium, phosphorus, carbon dioxide, glucose, blood urea
nitrogen, cholesterol, triglycerides, and total protein concen-
trations were not affected by diclofenac, but some changes
were noted among sampling times. Notably, plasma calcium,
creatinine, cholesterol, and triglyceride concentrations were
slightly elevated at the 12 h sample collection (evening), pos-
sibly reflecting recent feeding or a diurnal rhythm. Plasma
gamma glutamyl transferase activity was detectable in only
59% of the samples.
In conclusion, turkey vultures seem to be remarkably tol-
erant to diclofenac compared to Gyps vultures [1,3,6]. This
presumably reflects basic physiological differences due to tax-
onomic distinctions between turkey vultures and Gyps species.
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If in fact turkey vultures are representative of New World
vultures, the toxicity and risk of diclofenac to these scavenging
birds would be predicted to be minimal. However, differences
in sensitivity among avian species seem to be the hallmark of
the cyclooxygenase-2 inhibitors, making such interspecific
predictions tenuous. Notably, the cyclooxygenase-2 inhibitors
carprofen and flunxin have been observed to evoke renal dis-
ease and gout in rather diverse species of birds (Harris’s hawk,
Parabuteo unicinctus; northern saw-whet owl, Aegolius acad-
icus; Maribou stork, Leptoptilos crumeniferus) [11]. Mortality
events in any species need to be investigated, and seemingly
unusual exposure routes to toxicants deserve consideration.
Use of alternative therapeutic NSAIDs (e.g., meloxicam) that
evoke effects through other mechanisms of action has been
advocated in regions where species at risk are known to exist
[9,11], and despite the tolerance of turkey vultures to diclo-
fenac, additional research in scavenging birds would seem
warranted.
Acknowledgement—This work was funded in part by the Royal So-
ciety for the Protection of Birds. We graciously thank James D. Elliot
Jr., Tyler Van Hook, Erik Hofmeister, and Carolyn Cray for technical
assistance and advice, and Rhys Green, Richard Cuthbert, David J.
Hoffman, and J. Lindsay Oaks for comments on the methods and
manuscript.
REFERENCES
1. Oaks JL, Gilbert M, Virani MZ, Watson RT, Meteyer CU, Rideout
BA, Shivaprasad HL, Ahmed S, Chaudhry MJI, Arshad M, Mah-
mood S, Ali A, Khan AA. 2004. Diclofenac residues as the cause
of vulture population decline in Pakistan. Nature 427:630–633.
2. Green RE, Newton I, Shultz S, Cunningham AA, Gilbert M, Pain
DJ, Prakash V. 2004. Diclofenac poisoning as a cause of vulture
population declines across the Indian subcontinent. J Appl Ecol
41:793–800.
3. Shultz S, Baral HS, Charman S, Cunningham AA, Das D, Ghal-
sasi GR, Goudar MS, Green RE, Jones A, Nighot P, Pain DJ,
Prakash V. 2004. Diclofenac poisoning is widespread in declining
vulture populations across the Indian subcontinent. Proc Royal
Soc Lond B 271(Suppl):S458–S460.
4. Green RE, Taggart MA, Das D, Pain DJ, Kumar CS, Cunningham
AA, Cuthbert R. 2006. Collapse of Asian vulture populations:
Risk of mortality from residues of the veterinary drug diclofenac
in carcasses of treated cattle. J Appl Ecol 43:949–956.
5. Green RE, Taggart MA, Senacha KR, Raghavan B, Pain DJ, Jhala
Y, Cuthbert R. 2007. Rate of decline of the oriental white-backed
vulture population in India estimated from a survey of diclofenac
residues in carcasses of ungulates. PLoS One 2:e686.
6. Swan GE, Cuthbert R, Quevedo M, Green RE, Pain DJ, Bartels
P, Cunningham AA, Duncan N, Meharg AA, Oaks JL, Parry-
Jones J, Shultz S, Taggart MA, Verdoorn G, Wolter K. 2006.
Toxicity of diclofenac to Gyps vultures. Biol Lett 2:279–282.
7. Meteyer CU, Rideout BR, Gilbert M, Shivaprasad HL, Oaks JL.
2005. Pathology and proposed pathophysiology of diclofenac poi-
soning in free-living and experimentally exposed oriental white-
backed vultures (Gyps bengalensis). J Wildl Dis 41:707–716.
8. Naidoo V, Duncan N, Bekker L, Swan G. 2007. Validating the
domestic fowl as a model to investigate the pathophysiology of
diclofenac in Gyps vultures. Environ Toxicol Pharmacol 24:260–
266.
9. Swan G, Naidoo V, Cuthbert R, Green RE, Pain DJ, Swarup D,
Prakash V, Taggart M, Bekker L, Das D, Diekmann J, Diekmann
M, Killian E, Meharg A, Patra RC, Saini M, Wolter K. 2006.
Removing the threat of diclofenac to critically endangered Asian
vultures. PLoS Biology 4:e66.
10. Sweetman S. 2006. Martindale—The Complete Drug Reference,
35th ed. Pharmaceutical Press, London, UK.
11. Cuthbert R, Parry-Jones J, Green RE, Pain DJ. 2007. NSAIDs
and scavenging birds: Potential impacts beyond Asia’s critically
endangered vultures. Biol Lett 3:90–93.
12. Henny CJ, Blus LJ, Kolbe EJ, Fitzner RE. 1985. Organophosphate
insecticide (famphur) topically applied to cattle kills magpies and
hawks. J Wildl Manag 49:648–658.
13. Henny CJ, Kolbe EJ, Hill EF, Blus LJ. 1987. Case histories of
bald eagles and other raptors killed by organophosphorus insec-
ticides topically applied to livestock. J Wildl Dis 23:292–295.
14. Langelier KM. 1993. Barbiturate poisoning of twenty-nine bald
eagles. In Redig PT, Cooper JE, Remple JD, Hunter DB, eds,
Raptor Biomedicine. University of Minnesota, Minneapolis, MN,
USA, pp 231–232.
15. Mineau P, Fletcher MR, Glaser LC, Thomas NJ, Brassard C,
Wilson LK, Elliott JE, Lyon LA, Henny CJ, Bollinger T, Porter
SL. 1999. Poisoning of raptors with organophosphorus and car-
bamate pesticides with emphasis on Canada, U.S. and U.K. J
Raptor Res 33:1–35.
16. Thomas NJ. 1999. Barbiturates. In Friend M, Franson JC, tech-
nical eds, Field Manual of Wildlife Diseases, General Field Pro-
cedures and Diseases of Birds. U.S. Geological Survey, Biolog-
ical Resources Division, Reston, VA, pp 349–350.
17. Klein PN, Charmatz K, Langenberg J. 1994. The effect of flunixin
meglumine (Banamine) on the renal function in northern bob-
white (Colinus virginianus): An avian model. Proceedings, An-
nual Conference of the American Association of Zoo Veterinar-
ians and Association of Reptilian and Amphibian Veterinarians,
Pittsburgh, PA, October 22–27, pp 129–131.
18. Baert K, De Backer P. 2003. Comparative pharmacokinetics of
three non-steroidal anti-inflammatory drugs in five species of
birds. Comp Biochem Physiol C 134:25–33.
19. Mulcahy DM, Tuomi P, Larsen RS. 2003. Differential mortality
of male spectacled eiders (Somateria fischeri) and king eiders
(Somateria spectabilis) subsequent to anesthesia with propofol,
bupivacaine, and ketoprofen. Journal of Avian Medicine and Sur-
gery 17:117–123.
20. Daughton CG, Ternes TA. 1999. Pharmaceuticals and personal
care products in the environment: Agents of subtle change? En-
viron Health Perspect 107(Suppl 6):907–938.
21. Kolpin DW, Furlong ET, Meyers MT, Thurman EM, Zaugg SD,
Barber LB, Buxton HT. 2002. Pharmaceuticals, hormones, and
other organic wastewater contaminants in U.S. streams, 1999–
2000: A national reconnaissance. Environ Sci Technol 36:1202–
1211.
22. Beaty BJ, Calisher CH, Shope RE. 1989. Arboviruses. In Schmidt
NJ, Emmons RW, eds, Diagnostic Procedures for Viral, Rick-
ettsial and Chlamydial Infections, 6th ed. American Public Health
Association, Washington, DC, pp 797–856.
23. Docherty DE, Long RR, Griffin KM, Saito EK. 2004. Corvidae
feather pulp and West Nile Virus detection. Emerg Infect Dis 10:
907–909.
24. Taggart MA, Senacha KR, Green RE, Jhala YV, Raghavan B,
Rahmani AR, Cuthbert R, Pain DJ, Meharg AA. 2007. Diclofenac
residues in carcasses of domestic ungulates available to vultures
in India. Environ Int 33:759–765.
25. Cray C, Zaias J. 2004. Laboratory procedures. In Rupley A,
Schulte M, eds, Veterinary Clinics of North America: Exotics
Animal Practice. Elsevier, New York, NY, USA, pp 487–518.
26. Cray C, Rodriguez M, Zaias J. 2007. Protein electrophoresis of
psittacine plasma. Vet Clin Pathol 36:67–72.
27. Lunn DJ, Thomas A, Best N, Spiegelhalter D. 2000. WinBUGS—
A Bayesian modelling framework: Concepts, structure, and ex-
tensibility. Stat Comp 10:325–337.
28. Gee GF, Carpenter JW, Hensler GH. 1981. Species differences in
hematological values of captive cranes, geese, raptors, and quail.
J Wildl Manag 45:463–483.
29. Polo FJ, Celdran JF, Peinado VI, Viscor G, Palomeque J. 1992.
Hematological values for four species of birds of prey. Condor
94:1007–1013.
